✦ LIBER ✦

Phase II trial of intraperitoneal cisplatin combined with intravenous paclitaxel in patients with ovarian, primary peritoneal and fallopian tube cancer

✍ Scribed by Lisa M. Landrum; Johnny Hyde Jr.; Robert S. Mannel; D. Scott McMeekin; Kathleen N. Moore; Joan L. Walker

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Progression-free and overall survival of

✍ Joyce N. Barlin; Fanny Dao; Nadim Bou Zgheib; Sarah E. Ferguson; Paul J. Sabbati 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 170 KB

Phase 2 trial of carboplatin, paclitaxel

✍ Pedro F Escobar; Maurie Markman; Peter Rose; Kristine Zanotti; Kenneth Webster; 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 97 KB

Phase I feasibility study of intraperito

✍ Don S. Dizon; Michael W. Sill; Natalie Gould; Stephen C. Rubin; S. Diane Yamada; 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 162 KB

Phase II Trial of Intraperitoneal Cispla

✍ A. Husain; P. Sabbatini; D. Spriggs; D. Fennelly; C. Aghajanian; R. Barakat; J. 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 53 KB

Phase II evaluation of topotecan and nav

✍ Thomas J. Herzog; Matthew A. Powell; Janet S. Rader; Randall K. Gibb; Lynne Lipp 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 424 KB

A phase II trial of weekly docetaxel in

✍ Anna Berkenblit; Michael V. Seiden; Ursula A. Matulonis; Richard T. Penson; Caro 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 169 KB